[Federal Register Volume 79, Number 58 (Wednesday, March 26, 2014)]
[Notices]
[Page 16768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-06707]


-----------------------------------------------------------------------

 DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-98-2013]


Foreign-Trade Zone 93--Raleigh/Durham, North Carolina, 
Authorization of Production Activity, GlaxoSmithKline, PLC 
(Pharmaceutical Products), Zebulon, North Carolina

    On November 18, 2013, the Triangle J Council of Governments, 
grantee of FTZ 93, submitted a notification of proposed production 
activity to the Foreign-Trade Zones (FTZ) Board on behalf of 
GlaxoSmithKline, PLC, within FTZ 93--Site 6, in Zebulon, North 
Carolina.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (78 FR 70531-70532, 11-26-2013). The 
FTZ Board has determined that no further review of the activity is 
warranted at this time. The production activity described in the 
notification is authorized, subject to the FTZ Act and the Board's 
regulations, including Section 400.14.

    Dated: March 18, 2014.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2014-06707 Filed 3-25-14; 8:45 am]
BILLING CODE 3510-DS-P